| Authors: |
Morel KL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Sheahan AV; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Burkhart DL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Boufaied N; Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Canada., Liu Y; Department of Medical Biophysics, University of Toronto and Princess Margaret Cancer Center University Health Network, Toronto, Canada., Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cañadas I; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Roehle K; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Heckler M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Calagua C; Department of Medicine, Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Ye H; Department of Pathology, University of California at Los Angeles, Los Angeles, CA, USA., Pantelidou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Galbo P; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA., Panja S; Department of Health Informatics, Rutgers School of Health Professionals, Newark, NJ, USA., Mitrofanova A; Department of Health Informatics, Rutgers School of Health Professionals, Newark, NJ, USA.; Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Wilkinson S; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Whitlock NC; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Trostel SY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hamid AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kibel AS; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sweeney CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Einstein DJ; Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Sowalsky AG; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., He HH; Department of Medical Biophysics, University of Toronto and Princess Margaret Cancer Center University Health Network, Toronto, Canada., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Balk SP; Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Labbé DP; Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Canada.; Division of Urology, Department of Surgery, McGill University, Montréal, Canada., Olson BM; Departments of Hematology and Medical Oncology and Urology, Emory University School of Medicine, Atlanta, GA, USA., Ellis L; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Leigh.Ellis@cshs.org.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Leigh.Ellis@cshs.org.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. Leigh.Ellis@cshs.org.; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Leigh.Ellis@cshs.org.; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA. Leigh.Ellis@cshs.org. |
